Tags
- 1:1
- 14 Days
- 3
- 4
- 6
- 7
- 7 Days
- 9
- 90 Days
- A
- Academic
- Accordance
- Accounting
- Achievement
- Acro
- Across
- Actual
- Adjustment
- Adjustments
- Administration
- Adult
- Adverse
- Adverse drug reaction
- Adverse event
- Adverse Events
- Ak Nz
- Algorithm
- Algorithms
- Allele
- Allocation
- Amendment
- An
- Ancestor
- Ancestral population
- Andromeda II
- Andromeda IX
- Anticoagulant
- Appendix
- Application
- Approved
- Approximation error
- Area codes 084 and 086
- Arm
- Arms
- Asia
- Asian
- At the Point
- Based on
- Baseline
- Bigbang Vol.1
- Bilirubin
- Bleeding
- BMC
- BMC Medicine
- Body
- Body of Evidence
- Calculated
- Caucasian
- Censored
- Centers
- Central Commission for Discipline Inspection
- Centralisation
- Characterized
- Chinese
- Chronic
- Classified
- Clinic
- Clinical
- Clinical application
- Clinical endpoint
- Clinical endpoints
- Clinical Practice
- Clinical research
- Clinical study design
- Clinical trial
- Clinical Trials
- ClinicalTrials.gov
- Clinician
- Cohort
- Collected
- Comparison
- Comparisons
- Complete
- Complete linkage
- Complex
- Complication
- Complications
- Comprised of
- Compulsion
- Computer
- Computer-generated
- Conclusion
- Conclusions
- Conducting
- Confer
- Confidence interval
- Consecutive
- Consent
- Considered
- Contemporary
- Contemporary Clinical Trials
- Copy
- Criteria
- CYP2C9
- CYP2C9*3
- CYP2D6
- Cytochrome
- Cytochrome P450
- Data
- Day 1
- Day 6
- Decisions
- Deemed
- Defined
- Demography
- Demonstrate
- Described
- Determined
- Deviation
- Difficulty
- Discrimination
- Disease
- Disequilibrium
- Diverse
- Domain
- Dosage
- Dose
- Dose adjustment
- Dose titration
- Dosing
- Dougla
- Douglas Manufacturing
- Drug
- East Asia
- Efficacy
- Eligibility
- Eligibility criteria
- Emoticon
- Empirical
- Employment
- Enabling
- End
- Endpoint
- Endpoints
- Enrollment
- Envelopes
- Epidemiology
- Episode
- Epoxide
- Error
- Estimation
- E.T.
- Ethics
- Ethics review
- Ethics review committee
- Ethnic group
- Ethnicity
- European
- European ancestry
- Evaluation
- Evidence
- Exclude
- Exclusion
- Experienced
- Facilitation
- Following
- Follow-up
- Food
- Food and Drug Administration
- Frequency
- Genetic
- Genotype
- Genotyping
- GlaxoSmithKline
- Good clinical practice
- Guidelines
- H1
- H7
- H8
- H9
- Haplotype
- Health
- Heparin
- Highlight
- High sensitivity
- Hospital
- Hypertension
- Identification
- Identifier
- If
- Impact
- Incidence
- Incidence rate
- Incidence rate ratio
- Inclusion and exclusion criteria
- Index
- Indian
- Indication
- Inequality
- Informed
- Informed consent
- Inhibition
- Initial
- Initiation
- Initiative
- INR
- Instantiation
- International
- Interpolation
- Intervention
- Judgment
- K
- Label
- Laboratory
- Latter
- Less
- Limit
- Limit superior and limit inferior
- Linear
- Linear interpolation
- Linkage
- Linkage disequilibrium
- Liver
- Liver disease
- Loading
- Loading dose
- Long term
- Long-term support
- Low molecular weight heparin
- LTD
- Maintenance
- Maintenance dose
- Major and minor
- Malabsorption
- Mandate
- Manufacturing
- Margin
- Mathematical optimization
- Mean percentage error
- Measurement
- Medical
- Medical guideline
- Medicine
- Meta-analysis
- Method
- Methods
- Ministry
- Ministry of Health
- Minor
- Modified
- Modified intention-to-treat
- Molecular mass
- Molecule
- Monitoring
- Most
- Multiculturalism
- Narrow
- National university
- National University Hospital
- New
- Normal
- Normal distribution
- Normalization
- Nucleic acid sequence
- Nucleotide
- Number
- Older
- Opaque
- Open-label trial
- Optimal maintenance
- Oral administration
- Over
- Packed to the Rafters
- Parameter
- Parameters
- Patient
- Peptic
- Peptic ulcer disease
- Percentage
- Perform
- Performance
- Personal identity
- Personalization
- Pharmaceutical drug
- Pharmacogenetics
- Pharmacogenomics
- Phenotype
- Physician
- Pitfall!
- Polymorphism
- Poor
- Population
- Prediction
- Presence
- Prevention
- Primary
- Primary and secondary
- Product
- Proportion
- Proportionality
- Protein
- Protein S
- Prothrombin time
- Protocol
- Publishing
- Pyrosequencing
- Race
- Raising and lowering indices
- Randomization
- Randomized controlled trial
- Randomized experiment
- Randomness
- Range
- Rate ratio
- Reaction
- Real World
- Recommended
- Recurrence
- Reducing
- Reduction
- Reference range
- Reflection
- Regimen
- Registered
- Registration
- Remainder
- Remains
- Reporting
- Require
- Requirement
- Research
- Resolution
- Result
- Review article
- Review Board
- Risk
- Routine
- Schedule
- Scientific
- Sealed
- Secondary
- Secondary endpoints
- Selection
- Self-report study
- Sensitivity
- Serious adverse event
- Set
- Shown
- Simulation
- Single
- Single-nucleotide polymorphism
- Some
- Sources
- South East
- Southeast Asia
- Specific
- Stable
- Standardization
- Start
- Strategie
- Strategy
- Studie
- Study protocol
- Subunit
- Superiority
- Surrogate
- Surrogate endpoint
- Surveillance
- Syndrome
- Table
- Tables
- Tablet
- Tertiary
- Tertiary referral hospital
- The Domain
- The first
- The Frequency
- The national
- The point
- Therapeutic index
- Therapy
- The Third Day
- Third
- Third Day
- Three
- Three Days
- Three Times
- Thrombosis
- Till
- Titration
- Traditional
- Transaminase
- Treating
- Trial
- Trial registration
- Trials
- Turnaround
- Turnaround time
- Two Days
- Ulcer
- Unavailability
- Uncontrolled
- United State
- University
- University Hospital
- Upper
- Urgent
- Utility
- Variability
- Variation
- Vein
- Venous thrombosis
- Versus
- Visit
- Vitamin
- Vitamin K
- VKORC1
- Warfarin
- Warfarin dosing
- Warfarin therapy
- Weight
- When
- Who
- Wild type
- Zygosity